Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 2,343,900 | 1,723,400 | 2,243,200 | 1,224,600 | 2,386,700 |
Marketable Securities | 2,093,500 | 1,228,800 | 1,665,800 | 2,313,400 | 2,041,700 |
Receivables | 1,933,500 | 1,959,600 | 2,088,900 | 1,958,500 | 2,017,300 |
Inventories | 751,800 | 776,700 | 770,200 | 929,900 | 916,600 |
Other current assets | 1,325,500 | 2,221,300 | 2,174,500 | 1,214,500 | 1,356,700 |
TOTAL | $8,448,200 | $7,909,800 | $8,942,600 | $7,640,900 | $8,719,000 |
Non-Current Assets | |||||
PPE Net | 3,138,100 | 3,077,500 | 3,013,800 | 3,601,200 | 3,538,900 |
Investments And Advances | 3,052,700 | 2,615,300 | 3,271,000 | 3,066,500 | 2,254,300 |
Intangibles | 9,138,500 | 9,430,500 | 8,695,900 | 8,826,400 | 8,819,100 |
Other Non-Current Assets | 3,706,500 | 3,254,500 | 2,522,200 | 2,153,900 | 2,160,900 |
TOTAL | $19,035,800 | $18,377,800 | $17,502,900 | $17,648,000 | $16,773,200 |
Total Assets | $27,484,000 | $26,287,600 | $26,445,500 | $25,288,900 | $25,492,200 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 382,200 | 377,100 | 378,000 | 370,500 | 342,300 |
Accrued Expenses | 2,429,100 | 2,318,000 | 2,435,000 | 2,861,200 | 2,578,500 |
Other current liabilities | N/A | 88,600 | 97,200 | N/A | N/A |
TOTAL | $4,432,200 | $3,210,900 | $3,148,700 | $3,295,200 | $3,174,900 |
Non-Current Liabilities | |||||
Long Term Debt | 4,458,200 | 5,948,500 | 5,943,200 | 5,936,500 | 5,931,100 |
aiOther Non-Current Liabilities | 1,781,400 | 1,778,800 | 1,789,901 | 1,391,301 | 1,513,300 |
TOTAL | $9,060,000 | $10,127,900 | $9,474,801 | $8,962,101 | $8,557,500 |
Total Liabilities | $13,492,200 | $13,338,800 | $12,623,500 | $12,257,300 | $11,732,400 |
Shareholders' Equity | |||||
Shares Outstanding, K | 180,442 | 184,447 | 193,893 | 196,709 | 201,483 |
Common Shares | 100 | 100 | 100 | 100 | 100 |
Retained earnings | 17,065,200 | 16,182,800 | 17,026,700 | 16,257,000 | 16,944,100 |
Other shareholders' equity | -96,500 | -257,100 | -227,800 | -248,500 | -255,200 |
TOTAL | $13,991,800 | $12,948,800 | $13,822,000 | $13,031,600 | $13,759,800 |
Total Liabilities And Equity | $27,484,000 | $26,287,600 | $26,445,500 | $25,288,900 | $25,492,200 |